pulsehealthbrief.com

UBC Okanagan mapped the enzymes that make mitraphylline — but that doesn’t mean a drug or mass supply is imminent With FDA Fast Track, Coya’s COYA 302 advances to a make-or-break Phase 2 readout expected in early 2027 Four weeks of lower-fat, higher-carb eating reduced biological-age markers in 65–75-year-olds, study finds When optimism bias meets viral nutrition claims: pick a starting point that won’t backfire When Fructose Flips the Survival Switch: What Happens at High Exposure and When to Act